Efficacy of Retreatment After Failed Direct-acting Antiviral Therapy in Patients With HCV Genotype 1–3 Infections
Julia Dietz(National Institute for Health and Care Excellence), F. Kocheise(Goethe University Frankfurt), Julius J. Schmidt, E. Giostra, Kai‐Henrik Peiffer(Goethe University Frankfurt), J. Balavoine(Universität Hamburg), Katrin Matschenz(Institute for Interdisciplinary Medicine), Julian Schulze zur Wiesch(Universität Hamburg), Rudolf Stauber(Medical University of Graz), Thomas Discher, P. Schulze(Universität Hamburg), Stefan Mauss(Center for HIV and Hepatogastroenterology), Rolf W. Günther(Goethe University Frankfurt), Christoph Neumann‐Haefelin(University of Freiburg), Hartwig Klinker(University of Würzburg), J. Hampe(Universität Hamburg), Beat Müllhaupt(University Hospital of Zurich), Christoph Antoni(Heidelberg University), H. Heinzow, Stefan Zeuzem(Goethe University Frankfurt), H. Wedemeyer(Hanover College), G. Hilgard, A. Rauch, Sandra Ciesek(Goethe University Frankfurt), Johanna Backhus(Universität Ulm), Andreas Herrmann(DWI – Leibniz Institute for Interactive Materials), Ulrich Spengler(University of Bonn), K. Deterding(Universität Ulm), Andrea De Gottardi(Ente Ospedaliero Cantonale), Tobias Boettler(University of Freiburg), D. Hoffmann, M. Berning, Julia Fischer(University of Cologne), Christoph Sarrazin(St. Josefs Hospital), Johannes Vermehren, Holger Hinrichsen(Kiel University), Andreas Stallmach(Jena University Hospital), Barbara Seegers(Clinical Research Center Kiel), Peter Buggisch(Institute for Interdisciplinary Medicine), Eugen Zizer(Universität Ulm), Thomas Berg(Leipzig University of Applied Sciences), Christoph P. Berg(University of Tübingen), Annemarie Berger(Goethe University Frankfurt), Janina Trauth, David Semela(Kantonsspital St. Gallen), N. Semmo, M. Gress, Felix Braun(Amsterdam UMC Location University of Amsterdam), Christian M. Lange(Goethe University Frankfurt), Felix Piecha(Universität Hamburg)
Cited by 13
Related Papers
Identification of a Novel Coronavirus in Patients with Severe Acute Respiratory Syndrome
|New England Journal of Medicine|2003|4.8k
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
|The Lancet. Gastroenterology & hepatology|2016|2k
ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis
|New England Journal of Medicine|2014|877
NOD2 (CARD15) mutations in Crohn’s disease are associated with diminished mucosal α-defensin expression
|Gut|2004|798
Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection
|New England Journal of Medicine|2017|565